| Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation C Yao, T Veleva, L Scott Jr, S Cao, L Li, G Chen, P Jeyabal, X Pan, ... Circulation 138 (20), 2227-2242, 2018 | 689 | 2018 |
| Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation A El-Armouche, P Boknik, T Eschenhagen, L Carrier, M Knaut, U Ravens, ... Circulation 114 (7), 670-680, 2006 | 354 | 2006 |
| Inhibition of Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium S Sossalla, N Fluschnik, H Schotola, KR Ort, S Neef, T Schulte, ... Circulation research 107 (9), 1150-1161, 2010 | 299 | 2010 |
| Atrial myocyte NLRP3/CaMKII nexus forms a substrate for postoperative atrial fibrillation J Heijman, AP Muna, T Veleva, CE Molina, H Sutanto, M Tekook, Q Wang, ... Circulation research 127 (8), 1036-1055, 2020 | 285 | 2020 |
| β-Adrenergic stimulation and myocardial function in the failing heart A El-Armouche, T Eschenhagen Heart failure reviews 14 (4), 225-241, 2009 | 284 | 2009 |
| The ACE-2 in COVID-19: foe or friend? R Dalan, SR Bornstein, A El-Armouche, RN Rodionov, A Markov, ... Hormone and Metabolic Research 52 (05), 257-263, 2020 | 222 | 2020 |
| Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure A El-Armouche, L Pohlmann, S Schlossarek, J Starbatty, YH Yeh, S Nattel, ... Journal of molecular and cellular cardiology 43 (2), 223-229, 2007 | 218 | 2007 |
| Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts A El-Armouche, T Pamminger, D Ditz, O Zolk, T Eschenhagen Cardiovascular research 61 (1), 87-93, 2004 | 192 | 2004 |
| Unfavourable consequences of chronic cardiac HIF-1α stabilization M Hölscher, K Schäfer, S Krull, K Farhat, A Hesse, M Silter, Y Lin, ... Cardiovascular research 94 (1), 77-86, 2012 | 179 | 2012 |
| Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation AFG Godier-Furnémont, M Tiburcy, E Wagner, M Dewenter, S Lämmle, ... Biomaterials 60, 82-91, 2015 | 171 | 2015 |
| Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue M Tiburcy, M Didié, O Boy, P Christalla, S Döker, H Naito, BC Karikkineth, ... Circulation research 109 (10), 1105-1114, 2011 | 164 | 2011 |
| Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes L Pohlmann, I Kröger, N Vignier, S Schlossarek, E Krämer, C Coirault, ... Circulation research 101 (9), 928-938, 2007 | 164 | 2007 |
| Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes H Mehel, J Emons, C Vettel, K Wittköpper, D Seppelt, M Dewenter, S Lutz, ... Journal of the American College of Cardiology 62 (17), 1596-1606, 2013 | 163 | 2013 |
| Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes A El‐Armouche, T Rau, O Zolk, D Ditz, T Pamminger, WH Zimmermann, ... The FASEB journal 17 (3), 1-23, 2003 | 159 | 2003 |
| Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase–deficient mice YH Zhang, MH Zhang, CE Sears, K Emanuel, C Redwood, ... Circulation research 102 (2), 242-249, 2008 | 149 | 2008 |
| A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway LH Lehmann, ZH Jebessa, MM Kreusser, A Horsch, T He, M Kronlage, ... Nature medicine 24 (1), 62-72, 2018 | 145 | 2018 |
| Function and regulation of serine/threonine phosphatases in the healthy and diseased heart J Heijman, M Dewenter, A El-Armouche, D Dobrev Journal of molecular and cellular cardiology 64, 90-98, 2013 | 145 | 2013 |
| Parthenogenetic stem cells for tissue-engineered heart repair M Didié, P Christalla, M Rubart, V Muppala, S Döker, B Unsöld, ... The Journal of clinical investigation 123 (3), 1285-1298, 2013 | 134 | 2013 |
| Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation M Greiser, HR Neuberger, E Harks, A El-Armouche, P Boknik, S de Haan, ... Journal of molecular and cellular cardiology 46 (3), 385-394, 2009 | 129 | 2009 |
| Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy A El-Armouche, K Wittköpper, F Degenhardt, F Weinberger, M Didié, ... Cardiovascular research 80 (3), 396-406, 2008 | 127 | 2008 |
